Neurofeedback vs. Methylphenidate to treat ADHD
This study from researchers in the UK, Italy and Germany sought to compare the effectiveness of neurofeedback contrasted with popular ADHD drug methylphenidate in treating the disorder. This disorder currently affects an estimated 3-5% of schoolchildren today, causing impulsiveness and hyperactivity, and frequently causing problems at home and school.
Participants in this study were between 8-12 years old. Researchers examined the differences in their overall brain function after different participant groups underwent neurofeedback therapy versus treatment via methylphenidate. Their findings were that neurofeedback provided an effective alternative treatment for those who preferred a non-pharmaceutical method.
To read more, click here.